Viewing Study NCT01890161


Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2025-12-24 @ 12:08 PM
Study NCT ID: NCT01890161
Status: COMPLETED
Last Update Posted: 2016-02-05
First Post: 2013-06-26
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma
Sponsor: Axikin Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module